• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RHY 7.69% 8.4¢

RHYTHM BIOSCIENCES LIMITED

Rhythm Biosciences Limited is an Australia-based medical diagnostics company. The Company... Rhythm Biosciences Limited is an Australia-based medical diagnostics company. The Company is engaged in the development and commercialization of Australian medical diagnostics technology for sale in domestic and international markets. The Company’s ColoSTAT a blood-base cancer test, designed for the early detection of colorectal cancer, has been developed initially as an alternative screening test for individuals unable to or unwilling to use available screening modalities. ColoSTAT is indicated to screen adults, aged 40 to 85, at average risk for developing Colorectal Cancer (CRC). The test-kit measures five specific biomarkers in the blood that either increase or decrease in quantity when CRC tumors are present.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RHY 24/04/24 4 997
24/04/24 Last post  borano Comments Created with Sketch.  4  Views Created with Sketch.  997 
RHY
News: RHY Rhythm Biosciences Appoints David Atkins As CEO
24/04/24 0 105
24/04/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  105 
RHY
Trading Halt
24/04/24 0 116
24/04/24 Last post  borano Comments Created with Sketch.  0  Views Created with Sketch.  116 
RHY 24/04/24 3 686
24/04/24 Last post  goedy Comments Created with Sketch.  3  Views Created with Sketch.  686 
RHY
No news is good news?
22/04/24 7 1.3K
22/04/24 Last post  borano Comments Created with Sketch.  7  Views Created with Sketch.  1.3K 
RHY 22/04/24 46 8.9K
22/04/24 Last post  ShmoShady Comments Created with Sketch.  46  Views Created with Sketch.  8.9K 
RHY
New CEO
15/04/24 5 2.2K
15/04/24 Last post  ShmoShady Comments Created with Sketch.  5  Views Created with Sketch.  2.2K 
RHY
Blood-Based Screening for Colorectal Cancer Promising but Still Lacks Robust Efficacy
10/04/24 2 946
10/04/24 Last post  borano Comments Created with Sketch.  2  Views Created with Sketch.  946 

See All Discussions arrow Created with Sketch.

Timeline

Dr David Atkins appointed Chief Executive Officer of Rhythm
24 Apr 11:20
 
Rhythm Maintains ISO Certification
23 Apr 09:27
 
Change in substantial holding - Otto Buttula
02 Apr 09:43
 
Change of Director's Interest Notice - Trevor Lockett
27 Mar 08:38
 
Change of Director's Interest Notice - Lou Panaccio
27 Mar 08:38
 
Change of Director's Interest Notice - Otto Buttula
27 Mar 08:37
 
View More arrow Created with Sketch.
(20min delay)
Last
8.4¢
Change
-0.007(7.69%)
Mkt cap ! $20.66M
Open High Low Value Volume
9.0¢ 9.0¢ 8.4¢ $8.788K 100.3K

Buyers (Bids)

No. Vol. Price($)
4 32044 8.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.1¢ 161352 1
View Market Depth
Last trade - 15.58pm 25/04/2024 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.